Association of serum folate levels with mortality among cancer survivors: insights from NHANES 1999–2018
Cancer Treatment and Research Communications · 2026 · 49 · 101375
DOI: 10.1016/j.ctarc.2026.101375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Yang Qu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shua…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Peking Union Medical College Hospital.
Abstract (Originalsprache)
BACKGROUND: Previous studies on folate and cancer-related outcomes have reported inconsistent findings. This study examined the association between serum folate levels and mortality among cancer survivors using National Health and Nutrition Examination Survey (NHANES) 1999-2018 data. METHODS: We included 3524 cancer survivors aged ≥20 years with available serum folate and mortality data. Because of its right-skewed distribution, serum folate was log2-transformed and analyzed as both a continuous variable and quartiles. Quartiles were generated based on the distribution of log2-transformed serum folate in the final analytic sample. Cox proportional hazards models were used to estimate associations with all-cause, cancer-specific, and cardiovascular disease (CVD) mortality, adjusting for demographic, socioeconomic, lifestyle, and clinical covariates. RESULTS: In the fully adjusted model, log2-transformed serum folate was inversely associated with all-cause mortality during follow-up (HR = 0.89, 95% CI: 0.83-0.96, P < 0.01). Compared with Q3, participants in the lowest quartile had higher risks of all-cause mortality (HR = 1.52, 95% CI: 1.26-1.83, P < 0.001), cancer-specific mortality (HR = 2.03, 95% CI: 1.44-2.87, P < 0.001), and CVD mortality (HR = 1.60, 95% CI: 1.04-2.44, P = 0.03). The highest quartile showed a higher crude mortality proportion than Q3 and was not associated with lower mortality after full adjustment. CONCLUSIONS: Lower serum folate levels were associated with increased mortality among cancer survivors. The findings suggest a non-linear pattern, with more favorable outcomes at intermediate folate levels and no additional benefit at higher levels. Further prospective studies are needed to confirm these associations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China. Electronic addres…
Förderung
- Peking Union Medical College Hospital
Zitieren
APA
Qu, Y., Sun, J., Gao, L., & Zhou, Y. (2026). Association of serum folate levels with mortality among cancer survivors: insights from NHANES 1999–2018. Cancer Treatment and Research Communications, 49, 101375. https://doi.org/10.1016/j.ctarc.2026.101375
Vancouver
Qu Y, Sun J, Gao L, Zhou Y. Association of serum folate levels with mortality among cancer survivors: insights from NHANES 1999–2018. Cancer Treatment and Research Communications. 2026;49:101375. doi:10.1016/j.ctarc.2026.101375
BibTeX
@article{Qu2026,
author = {Qu, Yang and Sun, Juan and Gao, Lu and Zhou, Yidong},
title = {Association of serum folate levels with mortality among cancer survivors: insights from NHANES 1999–2018},
journal = {Cancer Treatment and Research Communications},
year = {2026},
volume = {49},
pages = {101375},
doi = {10.1016/j.ctarc.2026.101375}
}
EUVIMED